ACM
RXST icon

Aster Capital Management’s RxSight RXST Stock Holding History

Aster Capital Management’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14
Closed -$354 – 1207
2026
Q1 		$354 Buy
+14
New +$116 ﹤0.01% 799
2025
Q2 		– Sell
-1,859
Closed -$52.7K – 1504
2025
Q1 		$52.7K Buy
1,859
+1,511
+434% +$44.9K 0.01% 816
2024
Q4 		$12K Buy
+348
New +$15.7K ﹤0.01% 731

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Aster Capital Management's RXST Position: Q2 2026 in Review

Aster Capital Management sold out of RxSight (RXST) in Q2 2026, closing a stake of 14 shares — an estimated $354 sold.

Aster Capital Management first reported a position in RXST in Q4 2024 and held it in 3 quarters. The position peaked at $52.7K in Q1 2025. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Aster Capital Management reported no remaining RxSight position as of Q2 2026 after selling out during the quarter.
  • Aster Capital Management sold 14 RxSight shares in Q2 2026, an estimated $354.
  • Aster Capital Management first reported a position in RxSight in Q4 2024 and held it in 3 quarters.
  • Aster Capital Management's RxSight position peaked at $52.7K in Q1 2025.
  • 152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.